Anticardiolipin antibodies: clinical consequences of "low titers"

OBJECTIVE: To clarify the implications of low levels of immunoglobulin (Ig)-G or IgM anticardiolipin antibodies. METHODS: Women who underwent clinically indicated testing for antiphospholipid antibodies were divided into four groups based on results: 1) high-positive (lupus anticoagulant or more than 19 IgG binding units of anticardiolipin antibodies; N = 131), 2) low-positive IgG (fewer than 20 IgG binding units; N 93), 3) IgM only (more than nine IgM binding units; N 97), and 4) negative (N = 153). The development of antiphospholipid antibody-related disorders was assessed for the time interval from initial antibody testing to patient interview. The median study interval for each group was at least 4 years. Forty-five percent of women had repeat testing at the time of interview. RESULTS: Women in the high-positive group were more likely to develop at least one new medical complication than those in the low-positive IgG (odds ratio [OR] 4.49, 95% confidence interval [CI] 2.01-10.03), IgM only (OR 6.00, 95% CI 2.65-13.59), and negative (OR 9.11, 95% CI 3.92-21.2) groups. In contrast, the low-positive IgG, IgM only, and negative groups had similar risks for the development of new disorders. Twelve of 129 (9.3%) women in the low-positive IgG, IgM only, or negative groups had lupus anticoagulant or more than 19 IgG binding units on retesting. Half of these women developed at least one new disorder. CONCLUSION: Women with IgM or low levels of IgG anticardiolipin antibodies comprise distinct populations from those with lupus anticoagulant or moderate to high levels of anticardiolipin antibodies. These women are not at risk for antiphospholipid antibody-related disorders beyond the risk conferred by their medical histories. However, repeat testing is warranted with new or recurrent clinical symptoms.

This article has been cited by other articles:

				A. Martinez-Berriotxoa, G. Ruiz-Irastorza, M.-V. Egurbide, M. Garmendia, J. Gabriel Erdozain, I. Villar, and C. Aguirre Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus Lupus, October 1, 2007; 16(10): 810 - 816. [Abstract] [PDF]

				D. Caccavo, N.M. Pellegrino, F. Lorusso, M. Capotorto, M. Vacca, A. Vimercati, and R. Depalo Anticardiolipin antibody levels in women undergoing first in vitro fertilization/embryo transfer Hum. Reprod., September 1, 2007; 22(9): 2494 - 2500. [Abstract] [Full Text] [PDF]

				M M Shinzato, C Bueno, V S T. Viana, E F Borba, C R Goncalves, and E Bonfa Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis Lupus, December 1, 2005; 14(12): 953 - 958. [Abstract] [PDF]

				A Martinez-Berriotxoa, G Ruiz-Irastorza, M-V Egurbide, M Rueda, and C Aguirre Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus Lupus, December 1, 2004; 13(12): 927 - 933. [Abstract] [PDF]

				A. E. Frias Jr, R. A. Luikenaar, A. E. Sullivan, R. M. Lee, T F. Porter, D W. Branch, and R. M. Silver Poor Obstetric Outcome in Subsequent Pregnancies in Women With Prior Fetal Death Obstet. Gynecol., September 1, 2004; 104(3): 521 - 526. [Abstract] [Full Text] [PDF]

				M. A. Ozturk, I. C. Haznedaroglu, M. Turgut, and H. Goker Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia Clinical and Applied Thrombosis/Hemostasis, April 1, 2004; 10(2): 89 - 126. [Abstract] [PDF]

				G. Ruiz-Irastorza, M.-V. Egurbide, J. Ugalde, and C. Aguirre High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus Arch Intern Med, January 12, 2004; 164(1): 77 - 82. [Abstract] [Full Text] [PDF]

				R. M. Lee, M. A. Brown, D. W. Branch, K. Ward, and R. M. Silver Anticardiolipin and Anti-{beta}2-Glycoprotein-I Antibodies in Preeclampsia Obstet. Gynecol., August 1, 2003; 102(2): 294 - 300. [Abstract] [Full Text] [PDF]

				D. W. Branch and M. A. Khamashta Antiphospholipid Syndrome: Obstetric Diagnosis, Management, and Controversies Obstet. Gynecol., June 1, 2003; 101(6): 1333 - 1344. [Abstract] [Full Text] [PDF]

				J Balasch and R Cervera Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective Lupus, August 1, 2002; 11(8): 467 - 477. [Abstract] [PDF]

				E N Harris and S S Pierangeli Revisiting the anticardiolipin test and its standardization Lupus, May 1, 2002; 11(5): 269 - 275. [Abstract] [PDF]

				B. G. Macik, J. H. Rand, and B. A. Konkle Thrombophilia: What's a Practitioner to Do? Hematology, January 1, 2001; 2001(1): 322 - 338. [Abstract] [Full Text] [PDF]

				S. W. Reddel and S. A. Krilis Testing for and Clinical Significance of Anticardiolipin Antibodies Clin. Vaccine Immunol., November 1, 1999; 6(6): 775 - 782. [Full Text] [PDF]

				D. Tanne, L. D'Olhaberriague, L. R. Schultz, L. Salowich-Palm, K. L. Sawaya, and S. R. Levine Anticardiolipin antibodies and their associations with cerebrovascular risk factors Neurology, April 1, 1999; 52(7): 1368 - 1368. [Abstract] [Full Text] [PDF]

				R. M. Silver, D. W. Branch, J. R. Scott, C. A. Laskin, C. Bombardier, and K. Spitzer Prednisone and Aspirin in Women with Recurrent Fetal Loss N. Engl. J. Med., November 27, 1997; 337(22): 1629 - 1630. [Full Text]

				J. A. Hill Immunotherapy for Recurrent Pregnancy Loss: "Standard of Care of Buyer Beware" Reproductive Sciences, November 1, 1997; 4(6): 267 - 273. [PDF]

				S. R. Levine, L. Salowich-Palm, K. L. Sawaya, M. Perry, H. J. Spencer, H. J. Winkler, Z. Alam, and J. L. Carey IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death : A Prospective Cohort Study Stroke, September 1, 1997; 28(9): 1660 - 1665. [Abstract] [Full Text]

				O. Shibolet, M. J. Schwaber, M. Brezis, A. J.P. Sandison, Y. P. Panayiotopoulos, P. R. Taylor, M. D. Lockshin, M. R. Toglia, and J. G. Weg Venous Thromboembolism during Pregnancy N. Engl. J. Med., December 12, 1996; 335(24): 1846 - 1847. [Full Text]